Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Universidad San Carlos

InstitutionResearch output, impact & collaborations

Universidad San Carlos is a institution indexed in PICO Portal from OpenAlex.

What is known about Universidad San Carlos?

PICO Portalrecord summary

Universidad San Carlos is a research organisation in Asunción, PY. OpenAlex records 1,374 works and 23,008 citations for it. 709 researchers list it as their most recent affiliation.

How many works does Universidad San Carlos have?

PICO Portalindexed works

Universidad San Carlos has 1,374 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Universidad San Carlos have?

PICO Portalcitation count

Universidad San Carlos has 23,008 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Universidad San Carlos?

PICO Portalresearcher count

Universidad San Carlos has 709 researchers in the PICO Portal index.

What is the average h-index at Universidad San Carlos?

PICO Portalavg h-index

Universidad San Carlos has an average h-index of 47 in OpenAlex.

What is the ROR of Universidad San Carlos?

PICO Portalror

The ROR for Universidad San Carlos is on the source record.

What is the OpenAlex record for Universidad San Carlos?

PICO Portalopenalex

The OpenAlex for Universidad San Carlos is on the source record.

Who are the most-cited researchers behind Universidad San Carlos?

PICO Portaltop researchers by citations
1
Vincent A. Miller · Lung Cancer Treatments and Mutations
1,166 works91,125 citations
2
Kaijun Wang · Cardiac Valve Diseases and Treatments
73 works4,730 citations
3
Boxiong Tang · Chronic Lymphocytic Leukemia Research
89 works1,020 citations
4
Bálint File · Neural and Behavioral Psychology Studies
40 works541 citations

What are the most-cited papers on Universidad San Carlos?

PICO Portalmost cited works
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
Proceedings of the National Academy of Sciences. 20044,354 CitationsOPEN ACCESS
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
Genome Medicine. 20173,771 CitationsOPEN ACCESS
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
William Pao, Vincent A. Miller, Katerina Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, Harold Varmus
PLoS Medicine. 20053,538 CitationsOPEN ACCESS
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers
Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely
Clinical Cancer Research. 20132,497 CitationsOPEN ACCESS
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Molecular Cancer Therapeutics. 20172,408 CitationsOPEN ACCESS

How much of the research on Universidad San Carlos is open access?

PICO Portalopen access share
83%OPEN ACCESS
Gold
25%
Green
33%
Hybrid
0%
Bronze
25%
Closed
17%

Related on PICO Portal

470M+ articles · 14-day free trial